查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609161

神經病學病患監測市場：按設備、疾病類型和最終用戶分類 - 全球預測 2025-2030

Neurology Patient Monitoring Market by Device (Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors), Disease Type (Epilepsy, Parkinson's Disease, Sleep Disorders), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年神經病學病患監測市場價值為51.8億美元，預計到2024年將達到55.5億美元，複合年成長率為7.90%，預計到2030年將達到88.4億美元。

神經病學病患監測市場包括透過評估各種生理和解剖參數來追蹤神經狀況的技術和設備。這個市場對於治療癲癇、創傷性腦損傷、帕金森氏症和中風等疾病至關重要。神經病學病患監測的需求在於需要對神經系統疾病進行準確診斷和有效管理，從而實現即時資料收集和關鍵決策以改善患者治療結果。應用範圍包括醫院、診所和居家照護，最終用戶包括神經科、醫療保健專業人員和患者本身。關鍵的市場促進因素包括神經系統疾病盛行率的增加、監測技術的進步以及對神經系統健康意識的增強。此外，遠端醫療和遠端患者監護的成長創造了潛在的機會，特別是在醫療保健機會有限的地區。特別是，將人工智慧和機器學習整合到監控系統中進行預測分析和自動化，代表著一個快速成長的機會。

主要市場統計
基準年[2023] 51.8億美元
預測年份 [2024] 55.5億美元
預測年份 [2030] 88.4億美元
複合年成長率（%） 7.90%

然而，挑戰依然存在，例如複雜的監測設備和資源匱乏地區基礎設施有限帶來的高成本。辦理複雜的法規核准也是新參與企業進入市場的障礙。此外，數位監控解決方案中的資料隱私和安全問題需要仔細考慮和強大的解決方案。創新的最佳領域包括開發具有成本效益的攜帶式監測系統、增強資料分析能力以及改進方便用戶使用的介面以實現更廣泛的採用。整合各種感測技術的多模態監測系統的研究可以為市場帶來顯著的好處。這個市場的本質是競爭性和快速發展，其特點是新技術的不斷出現以及老牌和新興企業的進入。為了抓住市場機遇，企業應注重策略夥伴關係關係，開拓開拓的市場，並優先開拓以使用者為中心的產品。透過專注於全面的客戶支援並利用數位健康領域的進步，我們相信我們可以進一步加強我們的市場定位並推動永續成長。

市場動態：快速發展的神經病學病患監測市場的關鍵市場洞察

供需的動態交互作用正在改變神經病學病患監測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 對微創神經外科手術的偏好日益成長
    • 全球神經系統疾病負擔日益增加
    • 增加神經系統疾病意識提升計劃
  • 市場限制因素
    • 神經外科費用上漲
  • 市場機會
    • 融合先進技術
    • 有利的贖回場景
  • 市場挑戰
    • 世界神經外科醫師短缺

波特五力：駕馭神經病學病患監測市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解神經病學病患監測市場的外部影響

外部宏觀環境因素在塑造神經病學病患監測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解神經病學病患監測市場的競爭格局

對神經病學病患監測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣神經病學病患監測市場供應商的績效評估

FPNV 定位矩陣是評估神經科病患監測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了神經病學病患監測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對神經病學病患監測市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人們對微創神經外科的興趣日益濃厚
      • 世界各地神經系統疾病的負擔不斷增加
      • 擴大對神經系統疾病的認知計劃
    • 抑制因素
      • 神經外科費用上漲
    • 機會
      • 融合先進技術
      • 有利的贖回場景
    • 任務
      • 全球神經外科醫師短缺
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 神經病學病患監測市場：依設備分類

  • 腦氧飽和度儀
  • 腦波監測儀
  • 顱內壓監測儀
  • 磁振造影(MRI) 設備

第7章神經病學病患監測市場：依疾病類型

  • 癲癇
  • 帕金森氏症
  • 睡眠障礙
  • 中風和偏頭痛
  • 創傷性腦損傷 (TBI)

第 8 章 神經病學病患監測市場：依最終使用者分類

  • 門診手術中心
  • 診斷中心
  • 醫院
  • 神經病學中心

第9章美洲神經病學病患監測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太神經病學病患監測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的神經病學病患監測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Advanced Brain Monitoring, Inc.
  • Digitimer Ltd.
  • Dragerwerk AG & Co. KGaA
  • Edwards Lifesciences Corporation
  • General Electric Company
  • Integra LifeSciences Corporation
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic PLC
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • NovaSignal Corporation
  • RAUMEDIC AG
  • SOPHYSA SA
  • Spiegelberg GmbH & Co. KG.
Product Code: MRR-3A2E844FCDB5

The Neurology Patient Monitoring Market was valued at USD 5.18 billion in 2023, expected to reach USD 5.55 billion in 2024, and is projected to grow at a CAGR of 7.90%, to USD 8.84 billion by 2030.

The neurology patient monitoring market encompasses technologies and devices that track neurological conditions by assessing various physiological and anatomical parameters. This market is pivotal for managing conditions such as epilepsy, traumatic brain injuries, Parkinson's disease, and stroke. The necessity for neurology patient monitoring lies in the need for precise diagnosis and effective management of neurological disorders, enabling real-time data collection and critical decision-making for improved patient outcomes. Applications span across hospitals, clinics, and homecare settings, with end-users including neurologists, healthcare professionals, and patients themselves. Key market drivers include the increasing prevalence of neurological disorders, advancements in monitoring technologies, and heightened awareness of neurological health. Furthermore, the growth of telemedicine and remote patient monitoring creates potential opportunities, especially in regions with limited healthcare access. Notably, the integration of artificial intelligence and machine learning for predictive analytics and automation in monitoring systems represents a burgeoning opportunity for growth.

KEY MARKET STATISTICS
Base Year [2023] USD 5.18 billion
Estimated Year [2024] USD 5.55 billion
Forecast Year [2030] USD 8.84 billion
CAGR (%) 7.90%

However, challenges persist, including high costs associated with advanced monitoring devices and limited infrastructure in low-resource areas. Navigating the complexities of regulatory approvals also poses barriers to market entry for new players. Moreover, data privacy and security concerns in digital monitoring solutions demand careful consideration and robust solutions. The best areas for innovation include developing cost-effective and portable monitoring systems, enhancing data analytics capabilities, and improving user-friendly interfaces for broader adoption. Research into multimodal monitoring systems integrating different sensing technologies could yield significant market advantages. The nature of this market is highly competitive and rapidly evolving, characterized by the continuous emergence of new technologies and the participation of both established players and startups. To capitalize on market opportunities, businesses should focus on strategic partnerships, explore untapped markets, and prioritize user-centric product development. Emphasizing comprehensive customer support and leveraging advancements in digital health could further solidify market positioning and drive sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurology Patient Monitoring Market

The Neurology Patient Monitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising preference for minimally invasive neurosurgeries
    • Increasing burden of neurological disorders across the globe
    • Growing awareness programs for neurological disorders
  • Market Restraints
    • Elevated cost of neurosurgeries
  • Market Opportunities
    • Integration of advanced technologies
    • Favorable reimbursement scenario
  • Market Challenges
    • Shortage of neurosurgeons across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Neurology Patient Monitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurology Patient Monitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurology Patient Monitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurology Patient Monitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurology Patient Monitoring Market

A detailed market share analysis in the Neurology Patient Monitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurology Patient Monitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurology Patient Monitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurology Patient Monitoring Market

A strategic analysis of the Neurology Patient Monitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurology Patient Monitoring Market, highlighting leading vendors and their innovative profiles. These include Advanced Brain Monitoring, Inc., Digitimer Ltd., Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, General Electric Company, Integra LifeSciences Corporation, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Natus Medical Incorporated, Nihon Kohden Corporation, NovaSignal Corporation, RAUMEDIC AG, SOPHYSA SA, and Spiegelberg GmbH & Co. KG..

Market Segmentation & Coverage

This research report categorizes the Neurology Patient Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device, market is studied across Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors, and Magnetic Resonance Imaging (MRI) Devices.
  • Based on Disease Type, market is studied across Epilepsy, Parkinson's Disease, Sleep Disorders, Stroke & Migraine, and Traumatic Brain Injury (TBI).
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Hospitals, and Neurology Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising preference for minimally invasive neurosurgeries
      • 5.1.1.2. Increasing burden of neurological disorders across the globe
      • 5.1.1.3. Growing awareness programs for neurological disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Elevated cost of neurosurgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies
      • 5.1.3.2. Favorable reimbursement scenario
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of neurosurgeons across the globe
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurology Patient Monitoring Market, by Device

  • 6.1. Introduction
  • 6.2. Cerebral Oximeters
  • 6.3. Electroencephalography Monitors
  • 6.4. Intracranial Pressure Monitors
  • 6.5. Magnetic Resonance Imaging (MRI) Devices

7. Neurology Patient Monitoring Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Epilepsy
  • 7.3. Parkinson's Disease
  • 7.4. Sleep Disorders
  • 7.5. Stroke & Migraine
  • 7.6. Traumatic Brain Injury (TBI)

8. Neurology Patient Monitoring Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostic Centers
  • 8.4. Hospitals
  • 8.5. Neurology Centers

9. Americas Neurology Patient Monitoring Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neurology Patient Monitoring Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neurology Patient Monitoring Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Brain Monitoring, Inc.
  • 2. Digitimer Ltd.
  • 3. Dragerwerk AG & Co. KGaA
  • 4. Edwards Lifesciences Corporation
  • 5. General Electric Company
  • 6. Integra LifeSciences Corporation
  • 7. Koninklijke Philips N.V.
  • 8. Masimo Corporation
  • 9. Medtronic PLC
  • 10. Natus Medical Incorporated
  • 11. Nihon Kohden Corporation
  • 12. NovaSignal Corporation
  • 13. RAUMEDIC AG
  • 14. SOPHYSA SA
  • 15. Spiegelberg GmbH & Co. KG.

LIST OF FIGURES

  • FIGURE 1. NEUROLOGY PATIENT MONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROLOGY PATIENT MONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEUROLOGY PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEUROLOGY PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROLOGY PATIENT MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROLOGY PATIENT MONITORING MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CEREBRAL OXIMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROENCEPHALOGRAPHY MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE & MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEUROLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. NEUROLOGY PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. NEUROLOGY PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, 2023